Cardiology

Alirocumab cuts apheresis rates in familial hypercholesterolemia

Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce ...

Diabetes

Anagliptin effect on LDL in T2DM via ApoB-100 synthesis

(HealthDay)—In patients with type 2 diabetes being treated with a dipeptidyl peptidase-4 inhibitor (DPP4-I), use of anagliptin (ANA) may improve low-density lipoprotein cholesterol (LDL-C) levels, with the effect mediated, ...

Cardiology

Nutraceuticals alone or with ezetimibe aid in dyslipidemia

(HealthDay)—For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention, nutraceuticals alone or in combination with ezetimibe improve the lipid profile, ...

Cardiology

Geographic disparities in lower extremity amputation rates

A lower extremity amputation in a patient with peripheral artery disease—narrowing of the arteries that supply blood to the legs or feet—is the culmination of years of failure by the U.S. health system. Our study, published ...

Oncology & Cancer

Prostate cancer and blood lipids share genetic links

Numerous studies have suggested a relationship between cardiovascular disease risk factors and prostate cancer. A new study by researchers at the University of California, San Diego School of Medicine, with colleagues in ...

page 20 from 22